Колоректальный рак

Find Trial: ctDNA-Guided Surveillance After Colorectal Cancer Surgery - Oncology News Central

Find Trial: ctDNA-Guided Surveillance After Colorectal Cancer Surgery Oncology News Central

Microdroplets may reduce colorectal tumor growth at potentially lower cost

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed microscopic peptide droplets that deliver large amounts of gene-silencing molecules into cancer and immune cells, reducing the growth of hard-to-treat colorectal tumors by about 67% in mice. The patent-pending system uses small…

Q&A: How citizenship status impacts cancer screening rates

Patients in the United States who are not U.S. citizens are much less likely to get screened for breast, cervical and colorectal cancers, highlighting structural barriers to care, according to experts. Jenny S. Guadamuz, MSPH, PhD, an assistant professor of health policy and management at University of California…

Family cancer burden predicts risk in patients with inflammatory bowel disease

People with inflammatory bowel disease (IBD) who have several close relatives with colorectal cancer are significantly more likely to develop the disease themselves. This is demonstrated by a new Swedish registry study from Karolinska Institutet, published in the journal Gastroenterology. The findings raise the…

«Удивились, что я сам пришел в больницу»: жителю Эстонии диагностировали рак кишечника - Rus.Postimees.ee

«Удивились, что я сам пришел в больницу»: жителю Эстонии диагностировали рак кишечника Rus.Postimees.ee

Alcohol-linked cancer's toll extends far beyond the liver, with deaths rising across age groups

Alcohol-attributable cancer deaths in the U.S. doubled between 1990 and 2023, a new study found. The study also revealed that alcohol-linked cancer deaths are not limited to older adults or liver cancer. Among adults ages 20–54, colorectal cancer was the leading alcohol-attributable cancer death in men, while breast…

Major Study Finds Key Difference in Bowel Cancer Before 50 - Newsweek

Major Study Finds Key Difference in Bowel Cancer Before 50 Newsweek

Major study reveals key differences in bowel cancer before and after age 50

One of Australia's largest real-world studies of younger adults with advanced bowel cancer has identified important differences between cancers diagnosed before and after age 50, which could help doctors tailor treatments for younger adults more effectively.

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - Morningstar

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy Morningstar

Early-onset bowel cancer shows distinct biological and clinical features - news-medical.net

Early-onset bowel cancer shows distinct biological and clinical features news-medical.net

High-Dose Vitamin D3 Does Not Improve PFS in Metastatic Colorectal Cancer - The ASCO Post

High-Dose Vitamin D3 Does Not Improve PFS in Metastatic Colorectal Cancer The ASCO Post

BNTX Ends Colorectal Cancer Immunotherapy Study, Stock Down - Yahoo Finance

BNTX Ends Colorectal Cancer Immunotherapy Study, Stock Down Yahoo Finance

BioNTech Halts Phase 2 Trial of Individualized mRNA Cancer Vaccine Autogene Cevumeran in Colorectal Cancer - BioPharm International

BioNTech Halts Phase 2 Trial of Individualized mRNA Cancer Vaccine Autogene Cevumeran in Colorectal Cancer BioPharm International

Autogene Cevumeran Trial Terminated in Resected Colorectal Cancer

GALNT5 fuels colorectal cancer growth and drug resistance through PI3K/Akt/ABCC1 pathway - Bioengineer.org

GALNT5 fuels colorectal cancer growth and drug resistance through PI3K/Akt/ABCC1 pathway Bioengineer.org